ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0278350 | null | ENT examination, NOS|ENT examination|Ear, nose and throat examination (procedure)|Ear, nose and throat examination, NOS|Examination of ear, nose and throat|ENT - Ear, nose and throat examination|Ear, nose and throat examination | ENT examination |
C0334108 | The development of numerous polyps (growths that protrude from a mucous membrane). | polyposis|Polyposis, NOS|multiple polyps|Multiple Polyps|Multiple polyps (morphologic abnormality)|polyposi|Polyposis|Multiple polyps | Multiple polyps |
C0444139 | null | Gastric juice sample|Gastric fluid sample (specimen) | Gastric fluid sample |
C1277200 | null | normal concentration|Normal concentration (finding) | Normal concentration |
C0239987 | null | g immunoglobulin low|IGG, DECREASED|decreased igg|Decreased IgG | Deceased IgG |
C0751356 | An umbrella term for diseases which have chronic muscle inflammation and weakness of unknown etiology. The types of idiopathic inflammatory myopathy are further defined by either clinicopathologic criteria or by the presence of certain autoantibodies. | idiopathic inflammatory myopathies|Idiopathic Inflammatory Myositis|Myopathies, Idiopathic Inflammatory|Idiopathic inflammatory myopathy (disorder)|Idiopathic Inflammatory Myopathies|IIM|Myopathy, Idiopathic Inflammatory|Inflammatory Myopathies, Idiopathic|Inflammatory Myopathy, Idiopathic|Idiopathic inflammatory myositis|Idiopathic inflammatory myopathy|Idiopathic Inflammatory Myopathy|idiopathic inflammatory myopathy | Idiopathic Inflammatory Myopathies |
C0263666 | An inflammatory myopathy of childhood resulting in muscle weakness, and associated with a characteristic skin rash. | Childhood Dermatomyositis|Childhood type dermatomyositis (disorder)|Juvenile Dermatomyositis|Childhood type dermatomyositis|Dermatomyositis, childhood type|Dermatomyositis, Childhood Type|Childhood Type Dermatomyositis|Dermatomyositis, Juvenile|Myositis, Juvenile|JDM|Juvenile Myositis|Juvenile dermatomyositis|juvenile dermatomyositis | Dermatomyositis, Childhood Type |
C0044410 | null | ALFACALCIDOL|1α-hydroxycholecalciferol|alfacalcidol|1 alpha-hydroxyvitamin D3|1-hydroxycholecalciferol|1α-hydroxy-vitamin D3|Alfacalcidol|1-alpha-oxycholecalciferol|Alfacalcidol (substance)|Alpha D 3|1, hydroxy cholecalciferol|1-Hydroxycholecalciferol|hydroxycholecalciferol|1alpha-OHD3|1Alpha-Hydroxycholecalciferol|1 alpha-hydroxycholecalciferol|alphacalcidol|1α-hydroxyvitamin D3|(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol|1alpha-hydroxycholecalciferol|9,10-secocholesta-,7,10(19)-triene-1 alpha,3 beta-diol|(5Z,7E)-9,10-seco-5,7,10(19)-cholestatrien-1α,3β-diol|Product containing alfacalcidol (medicinal product)|1, Hydroxy cholecalciferol|Alpha-Calcidol|Alfacalcidol-containing product|9,10-secocholesta-5,7,10(19)-triene-1α,3β-diol|Alfacalcidolum | alfacalcidol |
C1520059 | null | Vitamin D analog (substance)|Vitamin D analogue|Vitamin D analog|Vitamin D Analog | Vitamin D Analog |
C0035245 | Physiological processes and properties of the RESPIRATORY SYSTEM as a whole or of any of its parts. | Physiological Phenomenon, Respiratory|Physiological Concept, Respiratory|Respiratory Physiological Concepts|Physiology, Respiratory|respiratory physiology|Respiratory Physiological Phenomenas|Physiological Phenomena, Respiratory|Physiological Concepts, Respiratory|Concept, Respiratory Physiological|Respiratory Physiological Phenomenons|Physiological Phenomenas, Respiratory|Respiratory Physiology|Phenomena, Respiratory Physiological|Respiratory Physiological Phenomenon|lung function|Concepts, Respiratory Physiological|Physiological Phenomenons, Respiratory|respiratory function|Respiratory Physiological Phenomena|Phenomenas, Respiratory Physiological|Respiratory Physiological Concept|Phenomenons, Respiratory Physiological|Phenomenon, Respiratory Physiological | Respiratory physiology |
C0549493 | null | ALVEOLITIS|alveolitis | Alveolitis |
C1265984 | null | Diffuse fibrosis (morphologic abnormality) | Diffuse fibrosis |
C0237607 | null | experience|practices|practice|experience (practice)|Practice Experience | Practice Experience |
C0040673 | Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. | Factor, Transfer|Transfer factor, NOS|factor transfer|Transfer Factor|factors transfer|Transfer factor|transfer factor | Transfer Factor |
C0022100 | Washing out a hollow organ (especially the stomach) by flushing with a fluid. | Irrigation|Irrigation (procedure)|Lavage, NOS|irrigation procedure|washing out|irrigation|Irrigation, NOS|irrigation therapy|Irrigation - action|lavage|LAVAGE|Irrigation - action (qualifier value)|lavage therapy|lavages|Lavages|irrigations|Lavage | Irrigation |
C0242629 | A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. | CD8 Cell|CD8 Lymphocytes|CD8 lymphocyte|cd8 cells|Lymphocyte positive for CD8 antigen|T8 Cell|CD8 Lymphocyte|CD8+ T Lymphocyte|Lymphocyte positive for CD8 antigen (cell)|Lymphocyte, T8|T8 Lymphocyte|CD8-Positive Lymphocyte|T-Lymphocytes, CD8-Positive|Cells, T8|CD8 Positive Lymphocytes|CD8+ T-Lymphocyte|CD8 Positive T Lymphocytes|CD8-Positive Lymphocytes|T-Lymphocyte, CD8-Positive|Cd8 Lymphocyte|CD8+ T Lymphocytes|CD8-Positive T-Lymphocytes|T8 lymphocyte|Cell, T8|CD8+ Lymphocyte|cd8 cell|T8 Lymphocytes|CD8+ T Cell|Lymphocytes, T8|Lymphocytes, CD8-Positive|Lymphocyte, CD8-Positive|CD8-Positive T-Lymphocyte|T8 Cells | CD8-Positive T-Lymphocytes |
C0010583 | Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. | 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide|Cyclophosphamidum|Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester|Cyclophosphamide|Cyclophosphanum|CYT|Cyclophosphamide-containing product|cyclophosphamide|cyt|Cytophosphane|Claphene|2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide, monohydrate|2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide|Syklofosfamid|cyts|N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide|(-)-cyclophosphamide|Mitoxan|CPM|Cyclophosphamid|Ciclofosfamide|(-)-Cyclophosphamide|Cyclophosphamide (substance)|N,N-bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-Oxide|Ciclofosfamida|N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-Oxide|Cyclophosphane|(RS)-Cyclophosphamide|CTX|Cyclophospham|Product containing cyclophosphamide (medicinal product)|cyclophosphane|(+-)-Cyclophosphamide|Cyclophosphan|CYCLOPHOSPHAMIDE | cyclophosphamide |
C0368953 | null | factor inhibitors viii|Anti-factor VIII|Factor VIII inhibitor|Factor VIII antibody|Factor VIII antibody (substance)|factor viii inhibitor|Circulating anti-factor VIII | Factor VIII antibody |
C0201101 | null | Catalase test, NOS|Catalase test (procedure) | Catalase test |
C0037118 | Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis. | Silicotuberculosis|Silicotuberculosis (disorder)|SILICOTUBERCULOSIS|Silicotuberculoses | Silicotuberculosis |
C0022209 | Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. | INH|Isonicotinylhydrazine|Isonicotinic hydrazide|4-Pyridinecarboxylic acid, hydrazide|Isoniazid-containing product|Isoniazid (substance)|Isonicotinic acid hydrazide|isonicotinic acid hydrazide|Product containing isoniazid (medicinal product)|Isonicotinic Acid Hydrazide|inh|isonicotinyl hydrazine|Isonicotinyl Hydrazine|Isoniazid|Isoniazida|Isonicotinohydrazide|ISONIAZID|isoniazid|Pyridine-4-carboxylic acid hydrazide|Isonicotinoylhydrazide|Isonicotinylhydrazide|Isonicotinsäurehydrazid|Hydrazide, Isonicotinic Acid | isoniazid |
C0036202 | An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands. | Besnier Boeck Schaumann Syndrome|Schaumann Disease|BESNIER-BOECK-SCHAUMANN DISEASE|Sarcoid NOS|schaumann's disease|schaumann syndrome|Syndrome, Schaumann|Boeck Sarcoid|Miliary Lupoid of Boeck|SCHAUMANN SYNDROME|schaumann disease|Benign Lymphogranulomatosis|Sarcoidosis (disorder)|sarcoid|Benign Lymphogranulomatosis, Schaumann's|Lupus pernio of Besnier|Lupus pernio, Besnier|Besnier-Boeck-Schaumann disease|Darier-Roussy Sarcoid|HUTCHINSON-BOECK SYNDROME|Sarcoidosis|Syndrome, Besnier-Boeck-Schaumann|Disease, Schaumann|Miliary lupoid of Boeck|boeck's disease|Boeck Disease|lymphogranulomatosis|Schaumann's Syndromes|Besnier Boeck Disease|Sarcoidosis, NOS|Sarcoid, Boeck's|Schaumann's Syndrome|Boeck Sarcoid, any site|Schaumann Syndrome|Darier-Roussy sarcoid|Syndrome, Schaumann's|BOECK SARCOID|Besnier-Boeck-Schaumann syndrome|Besnier Boeck disease|Boeck's sarcoidosis|Boeck's Sarcoid|Boecks Sarcoid|sarcoids|Boeck's Disease|SARCOIDOSIS|Sarcoid|Besnier-Boeck Disease|boeck's sarcoid|Besnier-Boeck-Schaumann Syndrome|LYMPHOGRANULOMATOSIS, BENIGN|sarcoidosis|Boecks Disease|lymphogranulomatosis (benign)|Sarcoidoses|Boeck's sarcoid|Benign lymphogranulomatosis of Schaumann | Sarcoidosis |
C0019655 | Infection resulting from exposure to the fungus HISTOPLASMA. It is worldwide in distribution and particularly common in the central and eastern states, especially areas around the Ohio and Mississippi River valleys. | Histoplasmosis|HISTOPLASMOSIS|Histoplasmosis (disorder)|Histoplasma Infection|Histoplasmosis NOS|Histoplasmosis, unspecified|Histoplasmosis, NOS|Infection, Histoplasma|histoplasmoses|Histoplasmoses|Infections, Histoplasma|histoplasmosis|Histoplasma Infections | Histoplasmosis |
C1263440 | null | null | diagnostic tests device |
C0037981 | Measurement of volume of air inhaled or exhaled by the lung. | Spirometry (procedure)|spirometry testing|Spirometry|spirometry test|spirometry|spirometry tests|SPIROMETRY|Spirometries | Spirometry |
C0554832 | null | Asthma monitoring (regime/therapy) | Asthma monitoring |
C1319853 | Asthmatic adverse reaction (e.g., BRONCHOCONSTRICTION) to conventional NSAIDS including aspirin use. | NSAID-induced Asthma|Aspirin-Induced Asthma|Asthma, Aspirin Induced|Asthmas, Aspirin-Induced|NSAID-induced Asthmas|Induced Asthma, Aspirin|Aspirin-induced asthma (disorder)|Asthmas, NSAID-induced|Aspirin-Induced Asthma Syndromes|Syndrome, Aspirin-Induced Asthma|Aspirin Induced Asthmas|Syndromes, Aspirin-Induced Asthma|Induced Asthmas, Aspirin|Asthma Syndrome, Aspirin-Induced|Aspirin-Induced Asthmas|Aspirin-induced asthma|Aspirin Induced Asthma Syndrome|Aspirin-Induced Asthma Syndrome|Asthmas, Aspirin Induced|Asthma Syndromes, Aspirin-Induced|Asthma, NSAID induced|Aspirin Induced Asthma|Asthma, NSAID-induced | Asthma, Aspirin-Induced |
C0396621 | null | Oral endotracheal intubation|Orotracheal intubation (procedure)|orotracheal intubation|Tracheal intubation via oral route | Orotracheal intubation |
C0040590 | Surgical formation of an opening into the trachea through the neck, or the opening so created. | TRACHEOSTOMY|tracheostomy procedure|Tracheostomy Procedure|Tracheostomies|tracheostomy|Tracheostomy|Tracheotomy|Tracheostomy, NOS | Tracheostomy procedure |
C1510538 | Counseling conducted via electronic or other non-face-to-face interactions. | Counseling, Distance|E-Therapy|E Therapy|E-Therapies|E Counseling|E-Counseling | Distance Counseling |
C0681867 | An experiment or clinical trial that includes a comparison (control) group. | Controlled Study|controlled study | Controlled Study |
C0021708 | Hospital units providing continuous surveillance and care to acutely ill patients. | INTENSIVE CARE UNIT|Intensive Care Units|Intensive Care Unit|ICU|Intensive care unit|ITU|intensive care unit (ICU)|ICU - Intensive care unit|care intensive units|intensive care unit|i c u|Care Units, Intensive|critical care unit|Intensive care unit (environment)|care critical unit|care critical units|Critical Care Unit|Unit, Intensive Care|i.c.u.|intensive care units|Intensive care units|care intensive unit|Care Unit, Intensive|Units, Intensive Care|CRITICAL CARE UNIT | intensive care unit |
C1519441 | Support all aspects of R&D from basic to clinical and may involve ancillary support activities such as patient care. They differ from program project grants in that they are usually developed in response to an institute initiative and subsequently receive continuous attention from its staff. Centers also may serve as regional or national resources for special research. | Specialized Center|P50 Program|P50 Mechanism | Specialized Center Grant |
C1305712 | null | Entire right main bronchus|Entire RMB - Right main bronchus|Entire right main bronchus (body structure) | Entire right main bronchus |
C0028043 | Physical and psychological dependence on nicotine. | Nicotine Addiction|Nicotine addiction|addiction nicotine|nicotine addiction|Nicotine dependence|Nicotine Dependence|addictions nicotine|Nicotine dependence (disorder)|Dependence, Nicotine|nicotine dependence|dependence nicotine | Nicotine Dependence |
C0851886 | Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally. | Pneumocystis Infection|Infections, Pneumocystis|Pneumocystis carinii Infections|Infection by Pneumocystis carinii|Pneumocystis carinii Infection|Infection, Pneumocystis|PNEUMOCYSTIS CARINII INFECTION|Pneumocystis Infections | Pneumocystis Infections |
C0458563 | null | Nasal ala|Ala nasi|Alar structure (body structure)|Ala of nose|Alar structure | Alar structure |
C0032326 | An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL. | PNEUMOTHORAX|Air in pleural space|Pneumothorax|Collapsed lung|free air in the chest outside the lung|Pneumothorax, NOS|Pneumothorax NOS|Pneumothorax (disorder)|pneumothorax|pneumothorax disorder | Pneumothorax |
C1549464 | <p>Client deceased.</p> | deceased | Deceased - ActIneligibilityReason |
C0427191 | null | General bone observation|Bone observation|Bone finding (finding) | Bone finding |
C0037253 | The framework that supports the soft tissues of vertebrate animals and protects many of their internal organs. The skeletons of vertebrates are made of bone and/or cartilage. | Skeletal bones, NOS|Skeletal system structure (body structure)|skeletal|Skeleton, NOS|skeletal systems|skeletal structures system|skeletal system|Skeleton as a whole|skeleton|Skeletal system structure|Skeletal system, NOS|Skeleton|Systema skeletale|Skeletal system|SKELETAL SYSTEM|Skeletal System | Skeletal system |
C0015879 | Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. | Ferritins|Ferritin|ferritins|Ferritin (substance)|ferritin | Ferritin |
C1283832 | null | Entire cerebral vessels|Entire cerebral vessels (body structure) | Entire cerebral vessels |
C0022245 | Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. | Isoprenalinum|Isopropyl Noradrenaline|1-(3,4-dihydroxyphenyl)-2-(isopropylamino)ethanol|Isopropylnorepinephrine|α-(isopropylaminomethyl)protocatechuyl alcohol|N-isopropyl-β-dihydroxyphenyl-β-hydroxyethylamine|Isoprénaline|N-Isopropylnoradrenaline|Isoproterenol-containing product|4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol|Isoproteronol|Isoproterenol|Noradrenaline, Isopropyl|Isoprenaline (substance)|isopropylnorepinephrine|1-(3,4-dihydroxyphenyl)-2-isopropylaminoethanol|isoproteronol|(±)-isoproterenol|N-Isopropylnorepinephrine|Isopropylnoradrenaline|(±)-isoprenaline|isoproterenol|Isopropyl noradrenaline|ISOPROTERENOL|Isoprenaline-containing product|Product containing isoprenaline (medicinal product)|Isopropylarterenol|isoprenaline|Isoprenalina|3,4-dihydroxy-α-[(isopropylamino)methyl]benzyl alcohol|1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-|Isoprenaline | isoproterenol |
C0006668 | A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. | thyrocalcitonin|CT - Calcitonin|Calcitonin-containing product|CALCITONIN|calcitonins|Calcitrin|Calcitonin|Calcitonin(1-32)|Calcitonin (substance)|Product containing calcitonin (medicinal product)|Thyrocalcitonin|calcitonin | calcitonin |
C0729093 | null | null | Synestrol |
C1262903 | null | peas|sativum, Pisum|pea|pisum sativum|garden pea|Pisum sativum | Pisum sativum |
C0011744 | The stable isotope of hydrogen. It has one neutron and one proton in the nucleus. | 2 H|Deuterium|Hydrogen 2|<sup>2</sup>H|Deuterium (substance)|Deuterium gas|^2^H|h 2|deuterium|Heavy hydrogen|Hydrogen-2|H2 isotope | Deuterium |
C0007412 | A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. | catecholamine|catecholamines|coumel|Catecholamine|Catecholamines|sympathin|Catecholamine (substance)|Sympathins|Catecholamine-containing product|Catecholamine, NOS|Product containing catecholamine (product) | Catecholamines |
C0025266 | Human males as cultural, psychological, sociological, political, and economic entities. | Human, Male|Man|men|man|Men|Man (person) | Male population group |
C0225360 | Spindle-shaped cells with characteristic CONTRACTILE PROTEINS and structures that contribute to the WOUND HEALING process. They occur in GRANULATION TISSUE and also in pathological processes such as FIBROSIS. | Myofibroblast|myofibroblasts|myofibroblast|Myofibroblasts|Myofibroblast (cell) | Myofibroblasts |
C0017626 | An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. | glial filament|Glial filament|Glial fibrillar acidic protein|Glial Intermediate Filament Protein|glial fibrillary acidic protein (GFAP)|GFA-Protein|Glial fibrillary acidic protein (substance)|GFA Protein|glial fibrillary acidic protein|GFAP|Glial Fibrillary Acid Protein|Glial fibrillary acidic protein|Glial Fibrillary Acidic Protein|Astroprotein|gfap | Glial Fibrillary Acidic Protein |
C0013604 | Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. | dropsy|Edematous|EDEMAS|Edema (finding)|edema|Edema|Edema, NOS|EDEMA (NOS)|excess fluid|Oedematous|Edemas|dropsies|interstitial edema|interstitial oedema|edematous|oedematous|oedema|Dropsy, NOS|edemas|Hydrops, NOS|EDEMA|OEDEMA|Dropsy|Interstitial oedema|SWELLING|Edema (morphologic abnormality)|Oedema, NOS|EDEMA NOS|Hydrops|Edema - lesion|Waterlogged|Oedema|oedemas|Interstitial edema|Oedema - lesion|watery swelling|swelling due to excess fluid|edema interstitial|Hydrops (morphologic abnormality)|hydrops | Edema |
C1440080 | Of or relating to the alveoli. | Alveolar | Alveolar |
C0678594 | The components and their relationship and manner of arrangement in constituting a whole. | structures|Structural|structure|Structure | Structure |
C0010853 | The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm. | Cytoskeletal System|cytoskeleton|Cytoskeletal|Cytoskeletons|Cellular Matrix|Cytoskeleton|intracellular skeleton | Cytoskeleton |
C1006958 | null | Serinus serinus|European serin|Serinus serinus (organism) | Serinus serinus |
C0027749 | Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM. | Nerve Fiber|fibres nerve|Nerve fiber, NOS|nerve fibre|nerve fiber|fiber nerve|Neurofibrum|Nerve fiber|Nerve fibre|nerve fibers|Nerve fiber (body structure)|Neurofibra|fibers nerve | Nerve Fibers |
C1180142 | null | Oblique plane | Oblique plane |
C1281262 | null | Entire rectovaginal septum (body structure)|Entire rectovaginal septum | Entire rectovaginal septum |
C0006121 | The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA. | Brain Stem|brain stem|BRAIN, BRAIN STEM|Cerebrus, Truncus|Brainstems|Cerebri, Truncus|Brainstem structure|Brainstem structure (body structure)|brain stems|BRAIN STEM|Brainstem|Truncus Cerebrus|Brain Stems|Truncus encephali|Brain stem|brainstem|Truncus Cerebri | Brain Stem |
C0040676 | Transferases are enzymes transferring a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme "donor:acceptor group transferase". (Enzyme Nomenclature, 1992) EC 2. | Substance with transferase mechanism of action|transferase|EC 2|transferases|TRANSFERASES|Substance with transferase mechanism of action (substance)|Transferase, NOS|Transferase|Transferases | Transferase |
C0079104 | Collection of pooled secretions of the posterior vaginal fornix for cytologic examination. | Cervical Smear|Smears, Cervical|Pap test|papanicolaou smear|cervical/vaginal smear|Vaginal Smears|Cervical Papanicolaou Test|papanicolaou smears|vaginal smears|pap test|Cervical Pap Test|Pap Smear|Smear, Cervical|Vaginal Smear|pap smears|Vaginal smears|Pap Test|Pap Smear Procedure|Cervical Smear Procedure|Papanicolaou smear|cervical smears|cervical smear|papanicolaou test|pap tests|cervix smear|cervical pap smear|Papanicolaou Test|Smears, Vaginal|cervical Pap test|PAP SMEAR|pap testing|pap smear|Cervical Smear Preparation|Cervical Smears|Papanicolaou Smear Procedure|cervical Papanicolaou test|Pap smear|Papanicolaou test|vaginal smear|Smear, Vaginal | Pap smear |
C0038056 | Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. | Expectoration|sputum|Sputums|Sputum|SPUTUM|Sputum (substance)|Expectoration, NOS|Portion of sputum | Sputum |
C0686919 | null | Finding related to non-diagnostic procedure|Non-diagnostic procedure, NOS|Finding related to non-diagnostic procedure (finding) | Non-diagnostic procedure finding |
C0003811 | Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. | Disorder of heart rhythm|ARRHYTHMIA CARDIAC (NOS)|cardiac arrhythmia|Arrhythmia, Cardiac|Heart Arrhythmias|Cardiac arrhythmias|HEART: RHYTHM|cardiac arrhythmias|arrhythmia|Dysrhythmias|Cardiac dysrhythmia, NOS|DYSRHYTHMIA|Cardiac arrhythmia NOS|Arrhythmia, NOS|Cardiac rhythm disturbances|Cardiac dysrhythmia, unspecified|Cardiac arrhythmia|dysrhythmia|CARDIAC ARRHYTHMIA|Abnormal heart rhythms|Cardiac rhythm irregular|Arrhythmias, Cardiac|Arrhythmia NOS|CARDIAC ARRHYTHMIA, IRREGULAR PULSE|Cardiac arrhythmia, NOS|cardiac dysrhythmia|Cardiac Dysrhythmia|arrhythmias|Cardiac rhythm, abnormal|CARDIAC ARRHYTHMIA (NOS)|Cardiac arrhythmia (disorder)|Arrythmia|Cardiac dysrhythmia|heart arrhythmia|Heart rhythm disorders|Dysrhythmia, Cardiac|cardiac rhythm disturbance|Irregular heartbeat|cardiac dysrhythmias|Arrhythmia|Cardiac Arrhythmias|Cardiac Arrhythmia|Irregular heart beat|Arrhythmias|Cardiac dysrhythmias|heart arrhythmias|DEFECT CONDUCTION (NOS)|ARRHYTHMIA | Cardiac Arrhythmia |
C0023981 | Studies in which variables relating to an individual or group of individuals are assessed over a period of time. | Studies, Longitudinal|longitudinal studies|longitudinal study|PROSPECTIVE|long-term study|prospective|Study, Longitudinal|Longitudinal Study|Longitudinal Studies | Longitudinal Studies |
C0004238 | Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. | atrial fibrillation (AF)|atrial fibrillation|auricular fibrillations|AFib|Fibrillation, Auricular|FIBRILLATION ATRIAL|AF - Atrial fibrillation|Auricular fibrillation|af|Auricular Fibrillations|ATRIAL FIBRILLATION|auricular fibrillation|AURICULAR FIBRILLATION|Quivering upper heart chambers resulting in irregular heartbeat|Auricular Fibrillation|atrial fibrillations|Fibrillation, Atrial|Atrial fibrillation|a fib|AF|Atrial Fibrillations|Atrial Fibrillation|afib|Fibrillations, Atrial|Fibrillations, Auricular|Atrial fibrillation (disorder) | Atrial Fibrillation |
C0023976 | A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME. | LONG QT SYNDROME|Long QT Syndrome|long qt syndrome|Long Q-T syndrome|Long QT syndrome, NOS|long q-t syndrome|Long QT syndrome|Prolonged Q-T interval syndrome, NOS|Prolonged Q-T interval syndrome|LQT|Ventricular arrhythmia associated with long QT syndrome|long q t syndrome|Long QT syndrome (disorder)|long QT syndrome | Long QT Syndrome |
C0002598 | An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. | Amiodarone-containing product|amiodarone|Amiodarone|Amiodarona|Amiodarone (substance)|2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|Product containing amiodarone (medicinal product)|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Methanone, (2-butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)-|Amiodaronum|AMIODARONE | amiodarone |
C0242972 | A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. (From Segen, Dictionary of Modern Medicine, 1992) | Diet, Protein-Restricted|Diet, Protein Restricted|Low-Protein Diet|diets low proteins|Low Protein Diet|Diet, Low Protein|Low-protein diet|diet low protein|Diets, Low-Protein|Diet, Low-Protein|protein restricted diet|LPD - Low protein diet|Protein-Restricted Diets|diet low proteins|low-protein diet|Low-Protein Diets|Decrease in protein content of the diet compared to the assessed baseline intake of protein for the individual. (Source: Academy of Nutrition and Dietetics Nutrition Informatics Committee 2013)|diets protein restricted|low-protein diets|Decreased protein diet (regime/therapy)|diets low protein|Low protein diet|low protein diet|Diets, Protein-Restricted|Protein Restricted Diet|Protein-Restricted Diet|LP - Low protein diet|Low protein diet (finding)|low protein|Decreased protein diet | Diet, Protein-Restricted |
C0022610 | A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613) | Encephalopathies, Hyperbilirubinemic|Encephalopathies, Bilirubin|Encephalopathy, Hyperbilirubinemic|Hyperbilirubinemic Encephalopathies|Kernicterus of newborn NOS|KERNICTERUS|Nuclear jaundice|Bilirubin Encephalopathy|bilirubin encephalopathy|Encephalopathy, Bilirubin|Kernicterus|Bilirubin encephalopathy|Kernicterus of newborn|Bilirubin Encephalopathies|Kernicterus of newborn (disorder)|Hyperbilirubinemic Encephalopathy|Kernicterus (morphologic abnormality)|NUCLEAR JAUNDICE|Kernicterus of newborn, NOS|kernicterus | Kernicterus |
C0424589 | null | vitality|energy | Vitality |
C0086511 | Replacement of the knee joint. | Arthroplasty knee|Repair of knee joint|Repair of knee joint, NOS|Total replacement of knee|Knee Replacement|Replacement Arthroplasties, Knee|Arthroplasty, Total Knee|Arthroplasty of the Knee|Replacement, Total Knee|Total Knee Arthroplasty|total knee arthroplasty|total knee replacement (TKR)|knees replacements|Arthroplasty of knee (procedure)|Arthroplasty Knee|Arthroplasties, Replacement, Knee|Arthroplasty of knee|Arthroplasty, Replacement, Knee|knee arthroplasty|knee prosthesis|Total knee arthroplasty|Arthroplasty of knee, NOS|Knee replacement|Knee joint replacement operation|Total knee replacement|Knee Arthroplasty|TOTAL KNEE ARTHROPLASTY|knees prosthesis|knee replacement|Knee Replacement Arthroplasties|Arthroplasties, Knee Replacement|arthroplasty of the knee|Arthroplasty, Knee Replacement|Replacement Arthroplasty, Knee|Knee arthroplasty|total knee replacements|Total Knee Replacement|Knee Replacement, Total|Knee Replacement Arthroplasty|Total Arthroplasty of the Knee|Knee Arthroplasty, Total|Arthroplasty of the knee|Arthroplasty, Knee|knee replacements|knees replacement|Total knee replacement (procedure)|arthroplasty of knee|total knee replacement | Knee Replacement Arthroplasty (procedure) |
C0937917 | A drug used under the name Latisse to increase the length, thickness, and darkness of eyelashes. It is being studied as a way to increase the growth of eyelashes and eyebrows in patients given chemotherapy for cancer. Bimatoprost is also used under the name Lumigan to treat glaucoma (a build-up of fluid in the eye). It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye. It is a type of prostaglandin analog. | (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide|Bimatoprost (substance)|bimatoprost|BIMATOPROST|5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-|Bimatoprost-containing product|Product containing bimatoprost (medicinal product)|Bimatoprost|5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-,(5Z)-|Bimatoprostum | bimatoprost |
C0017612 | Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris. | Glaucoma Simplex|Open angle glaucoma|OAG - Open-angle glaucoma|Glaucoma, open angle, pigmentary|pigment dispersion syndrome|glaucoma pigmentary|Glaucoma, Open-Angle|Glaucoma, open angle|Glaucoma, open-angle|Open-angle glaucoma, unspecified|Compensative Glaucoma|Glaucoma, Simple|Pigmentary Glaucoma|Simple Glaucoma|Open Angle Glaucoma|wide-angle glaucoma|Glaucoma, Compensated|Open-angle glaucoma, NOS|Pigmentary open-angle glaucoma|Wide-angle glaucoma NOS|Wide-angle glaucoma, NOS|open angle glaucoma|Simplex, Glaucoma|GLAUCOMA, OPEN ANGLE|Glaucoma, Compensative|pigmentary glaucoma|open-angle glaucoma|Glaucoma, Open Angle|glaucoma simple|Glaucoma simplex|Simplices, Glaucoma|Pigmentary glaucoma (disorder)|Open-angle glaucoma|simplex glaucoma|Open Angle Glaucomas|Wide-angle glaucoma|Pigmentary glaucoma|Compensated Glaucoma|Open-Angle Glaucomas|Glaucoma, Pigmentary|Melanocytic glaucoma|Open-angle glaucoma (disorder)|Open-Angle Glaucoma|angle glaucoma open|GLAUCOMA, NONCONGESTIVE|Open cleft glaucoma | Glaucoma, Open-Angle |
C0028840 | A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma. | Hypertensions, Ocular|Ocular Hypertension|OHT - Ocular hypertension|HYPERTENSION OCULAR|Hypertension, Ocular|ocular hypertension|Ocular Hypertensions|Pressure Behind Eyeballs|Ocular hypertension (disorder)|hypertension ocular|OH - Ocular hypertension|Ocular hypertension | Ocular Hypertension |
C0028841 | Abnormally low intraocular pressure often related to chronic inflammation (uveitis). | ocular hypotension|Low intraocular pressure|Decreased intraocular pressure (finding)|decreased intraocular pressure|decreased iop|INTRAOCULAR PRESSURE DECREASE|Hypotony, Ocular|Hypotony of eye (disorder)|Hypotony of eye, NOS|Globe hypotension|Ocular hypotony|Decreased intraocular pressure|hypotony ocular|decrease intraocular pressure|low intraocular pressure|Lowered intraocular pressure|ocular hypotony|Ocular Hypotony|Hypotony of eye|Hypotony of eye, unspecified|Hypotension, Ocular | Ocular Hypotension |
C0242339 | A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides. | Dyslipidaemia|Dyslipidemia|dyslipidemias|Dyslipidemia (disorder)|High blood cholesterol/triglycerides|dyslipidemia | Dyslipidemias |
C0337910 | Denotes the inhabitants of Thailand, a person from there, or their descendants elsewhere. | thai|Thais|Thaus|Thai|Thais (ethnic group)|THAI | Thais (Population Group) |
C0026093 | mobile, short-term residents who move usually to find work. | Nomad|Migrant (person)|migrants|Migrant|nomads|migrant|Nomads | Migrants |
C0036471 | A cutaneous pouch of skin containing the testicles and spermatic cords. | SCROTUM|Scrotum/Scrotal|Scrotal|Scrotal (qualifier value)|Scrotums|Scrotal structure (body structure)|scrotum|Scroto-|Scrotum|Scrotum, NOS|scrotums|Scrotal structure | Scrotum |
C0334471 | A poorly differentiated liposarcoma, characterized by the presence of solid sheets of primitive round mesenchymal cells and the absence of myxoid stroma. | Lipoblastic liposarcoma|round cell liposarcoma|Round cell liposarcoma|Round cell liposarcoma (morphologic abnormality)|Round Cell Liposarcoma|Round cell liposarcoma (disorder) | Round Cell Liposarcoma |
C0736905 | null | sac scrotal|scrotal sac|Scrotal sac | Scrotal sac |
C0014392 | In medicine, the removal of an organ or tumor in such a way that it comes out clean and whole, like a nut from its shell. | enucleation|Enucleation|Enucleation (procedure) | Enucleation procedure |
C0027532 | The neck muscles consist of the platysma, splenius cervicis, sternocleidomastoid(eus), longus colli, the anterior, medius, and posterior scalenes, digastric(us), stylohyoid(eus), mylohyoid(eus), geniohyoid(eus), sternohyoid(eus), omohyoid(eus), sternothyroid(eus), and thyrohyoid(eus). | neck muscles|Muscle of neck, NOS|Muscles of neck|Neck musculature|muscles neck of|Muscle group of neck|MUSCLES OF NECK|Musculi cervicis|Muscles, Neck|Neck muscle|Set of muscles of neck|Muscle, Neck|Muscles of Neck|of neck muscles|Neck Muscle|muscle neck|muscles of neck|muscles neck|Neck Muscles|neck muscle|Skeletal muscle structure of neck (body structure)|Muscle of neck|Muscular system of neck|Musculi colli|of neck muscle|Musculature of neck|Skeletal muscle structure of neck | Skeletal muscle structure of neck |
C0035231 | These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES. | Respiratory Muscles|respiratory muscle|Respiratory muscles|muscle respiratory|Muscles, Ventilatory|respiratory muscles|Respiratory Muscle|Ventilatory Muscle|Muscles, Respiratory|muscles respiratory|Ventilatory Muscles|Muscle, Ventilatory|Muscle, Respiratory | Respiratory Muscles |
C0578757 | null | Good neonatal condition at birth (finding)|normal infant|normal baby|infants normal|Well newborn|normal newborn|Healthy newborn|newborn normals|normal neonate|newborn normal | Good neonatal condition at birth |
C0022346 | A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. | icteric|Jaundice (finding)|Icterus NOS|Icterus, NOS|Jaundice, NOS|Icteric|Jaundiced|Icterus|jaundice|Yellow skin|ICTERUS|YELLOW SKIN|icterus|Yellowing of the skin|JAUNDICE|Jaundice | Icterus |
C0580327 | null | antibody tests|antibody testing|Antibody studies (procedure)|antibody test|antibodies test|antibodies tests|Antibody studies|antibody study | Antibody studies (procedure) |
C0447305 | null | mamelon|Mamelon (body structure) | Mamelon |
C0005373 | null | Bicuspid|Bicuspid (qualifier value) | Bicuspid |
C0011356 | null | null | DENTAL EVALUATION |
C0421231 | null | null | Epilepsy monitoring status - Driving licence |
C0023150 | null | law|Law|Laws|laws | Rules of conduct |
C0873188 | The monohydrate form of creatine similar or identical to endogenous creatine produced in the liver, kidneys, and pancreas. Creatine, in phosphate form, helps supply energy to muscle cells for contraction. After intense effort, when ATP deposits are depleted, creatine phosphate donates phosphate groups toward the fast synthesis of ATP. Dietary supplementation with creatine may improve muscle wasting associated with cancer and other chronic diseases. | creatine monohydrate|creatine supplement|monohydrate creatine|N-(Aminoiminomethyl)-N-methylglycine Monohydrate|N-(aminoiminomethyl)-N-methylglycine monohydrate|CREATINE MONOHYDRATE|Creatine monohydrate (substance)|Creatine monohydrate|Creatine Supplement|Creatine Monohydrate | creatine monohydrate |
C0242297 | Adding nutrients to the diet. | nutritional supplementation|dietary supplementation|Nutritional Supplementation|Supplementation|supplementation | Dietary Supplementation |
C0162670 | A group of muscle diseases associated with abnormal mitochondria function. | mitochondrial myopathy|Myopathies, Mitochondrial|MYOPATHY, MITOCHONDRIAL|Mitochondrial myopathy (disorder)|mitochondrial myopathies|mitochondrial cytopathy|Mitochondrial Myopathies|Mitochondrial myopathy|Ragged red myopathy|Mitochondrial Myopathy|myopathies mitochondrial|cytopathies mitochondrial|MITOCHONDRIAL MYOPATHY | Mitochondrial Myopathies |
C0010286 | An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine. | Methylglycocyamine|N-carbamimidoyl-N-methylglycine|((amino(Imino)methyl)(methyl)amino)acetic acid|alpha-Methylguanidino acetic acid|N-methyl-N-guanylglycine|Creatine (substance)|N-amidinosarcosine|creatine|Kreatin|Glycine, N-(aminoiminomethyl)-N-methyl-|(α-methylguanido)acetic acid|(alpha-Methylguanido)acetic acid|N-(aminoiminomethyl)-N-methylglycine|Creatin|(N-methylcarbamimidamido)acetic acid|Creatine|creatines|CREATINE | creatine |
C0023411 | A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans. | Betacoccus|LEUCONOSTOC|Leukonostoc|Leuconostoc, NOS|Genus Leuconostoc|Leuconostoc|leuconostoc|Genus Leuconostoc (organism)|Leuconostoc species | Leuconostoc |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.